Quick Answer
OS Therapies Inc reported Stockholders Equity of -$6.10 million for fiscal year 2025.
OS Therapies Inc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$6.10M | -86.6% |
| 2024 | -$3.27M | +86.4% |
| 2023 | -$24.02M | -36.8% |
| 2022 | -$17.56M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.64M | +614.4% | -26.4% |
| June 30, 2025 | $4.94M | +118.3% | +218.1% |
| March 31, 2025 | -$4.19M | +83.6% | -28.2% |
| December 31, 2024 | -$3.27M | +86.4% | -361.9% |
| September 30, 2024 | -$707.1K | +96.9% | +97.4% |
| June 30, 2024 | -$27.06M | -27.2% | -6.1% |
| March 31, 2024 | -$25.51M | -36.1% | -6.2% |
| December 31, 2023 | -$24.02M | -36.8% | -6.6% |
- OS Therapies Inc showed a decrease of -86.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, OS Therapies Inc’s stockholders equity has grown by 65.3% (from -$17.56 million to -$6.10 million).
- The most recent figure is from OS Therapies Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: